This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Harrer, G. Articles by Podzuweit, H. Search for Related Content PubMed PubMed Citation Articles by Harrer, G. Articles by Podzuweit, H. Social Bookmarking                         What's this?

Effectiveness and Tolerance of the Hypericum Extract LI 160 Compared to Maprotiline: A Multicenter Double-Blind Study

W.-D. Hübner

H. Podzuweit

A randomized, double-blind study examining the effectiveness and tolerance of a standardized hypericum preparation when compared to maprotiline was performed in a group of 102 patients with depression, in accordance with ICD-10, F 32.1. The study was conducted in the offices of neurology and psychiatry specialists. The patients received, over a period of 4 weeks, either 3 x 300 mg of the hypericum extract or 3 x 25 mg maprotiline pills of identical appearance. Effectiveness was determined using the Hamilton Depression Scale (HAMD), the Depression Scale according to von Zerssen (D-S), and the Clinical Global Impression Scale (CGI). The total score of the HAMD scale dropped during the 4 weeks of therapy in both treatment groups by about 50%. The mean values of the D-S scale and the CGI scale showed similar results, and after 4 weeks of therapy, no significant differences in either treatment group were noticed. The onset of the effects occurred up to the second week of treatment, but were observed earlier with maprotiline than with the hypericum extract. On the other hand, maprotiline treatment resulted in more cases of tiredness, mouth dryness, and heart complaints. (J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S24-S28).

Journal of Geriatric Psychiatry and Neurology, Vol. 7, No. 1, S24-S28 (1994)
DOI: 10.1177/089198879400700108


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. C Bell, W. R Ravis, H. M. Chan, and Y.-J. Lin Lack of Pharmacokinetic Interaction Between St. John's Wort and Prednisone Ann. Pharmacother., November 1, 2007; 41(11): 1819 - 1824. [Abstract] [Full Text] [PDF]

				A Szegedi, R Kohnen, A Dienel, and M Kieser Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine BMJ, March 5, 2005; 330(7490): 503. [Abstract] [Full Text] [PDF]

				P. J. Nathan Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology J Psychopharmacol, January 1, 2001; 15(1): 47 - 54. [Abstract] [PDF]

				H. Sommer and G. Harrer Placebo-Controlled Double-Blind Study Examining the Effectiveness of an Hypericum Preparation in 105 Mildly Depressed Patients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S9 - S11. [Abstract] [PDF]

				W.-D. Hubner, S. Lande, and H. Podzuweit Hypericum Treatment of Mild Depressions with Somatic Symptoms J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S12 - S14. [Abstract] [PDF]

				K.-D. Hansgen, J. Vesper, and M. Ploch Multicenter Double-Blind Study Examining the Antidepressant Effectiveness of the Hypericum Extract LI 160 J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S15 - S18. [Abstract] [PDF]

				H. Woelk, G. Burkard, and J. Grunwald Benefits and Risks of the Hypericum Extract LI 160: Drug Monitoring Study with 3250 Patients J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S34 - S38. [Abstract] [PDF]

				D. Johnson, H. Ksciuk, H. Woelk, E. Sauerwein-Giese, and A. Frauendorf Effects of Hypericum Extract LI 160 Compared with Maprotiline on Resting EEG and Evoked Potentials in 24 Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S44 - S46. [Abstract] [PDF]

				H. Wagner and S. Bladt Pharmaceutical Quality of Hypericum Extracts J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S65 - S68. [Abstract] [PDF]